Europe Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030

The Europe Arthritic Therapeutic Market would witness market growth of 4.8% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Arthritic Therapeutic Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $7,462.7 Million by 2030. The UK market is exhibiting a CAGR of 3.9% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.5% during (2023 - 2030).

Patient preferences, beliefs, and experiences play a significant role in shaping their adoption. Factors such as treatment efficacy, route of administration, frequency of dosing, potential side effects, and cost impact patients’ willingness to adhere to prescribed therapies. Establishing collaborative treatment plans that align with patient’s values, preferences, and lifestyle factors promotes shared decision-making between healthcare providers and patients.

Arthritic therapeutics are primarily utilized to manage the symptoms associated with arthritis, including pain, inflammation, stiffness, and swelling. Pharmacological interventions such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, analgesics, and disease-modifying antirheumatic drugs (DMARDs) help alleviate pain and reduce inflammation, improving mobility and enhancing the quality of life for patients with arthritis.

The aging population in Europe is accompanied by increased healthcare expenditure, as older adults require more medical services, treatments, and long-term care for chronic conditions, including arthritis. The aging population in Europe fuels demand for senior care services, specialized clinics, and multidisciplinary care teams focused on managing age-related health conditions, including arthritis. Thus, all these factors will uplift the regional market’s expansion in the coming years.

Free Valuable Insights: The Global Arthritic Therapeutic Market will Hit USD 112.6 Billion by 2030, at a CAGR of 5.1%

Based on Application, the market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others. Based on Product Type, the market is segmented into Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• AbbVie, Inc.
• Pfizer, Inc.
• Amgen, Inc.
• Novartis AG
• F.Hoffmann-La Roche Ltd.
• Viatris, Inc.
• Bausch Health Companies, Inc.
• Sanofi S.A.
• Merck & Co., Inc.
• Bristol-Myers Squibb Company

Europe Arthritic Therapeutic Market Report Segmentation

By Application

• Rheumatoid Arthritis
• Psoriatic Arthritis
• Osteoarthritis
• Ankylosing Spondylitis
• Others

By Product Type

• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Disease Modified Anti-rheumatoid Drugs (DMARDs)
• Biologics
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Arthritic Therapeutic Market, by Application
1.4.2 Europe Arthritic Therapeutic Market, by Product Type
1.4.3 Europe Arthritic Therapeutic Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5. Europe Arthritic Therapeutic Market, by Application
5.1 Europe Rheumatoid Arthritis Market, by Country
5.2 Europe Psoriatic Arthritis Market, by Country
5.3 Europe Osteoarthritis Market, by Country
5.4 Europe Ankylosing Spondylitis Market, by Country
5.5 Europe Others Market, by Country

Chapter 6. Europe Arthritic Therapeutic Market, by Product Type
6.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
6.2 Europe Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
6.3 Europe Biologics Market, by Country
6.4 Europe Others Market, by Country

Chapter 7. Europe Arthritic Therapeutic Market, by Country
7.1 Germany Arthritic Therapeutic Market
7.1.1 Germany Arthritic Therapeutic Market, by Application
7.1.2 Germany Arthritic Therapeutic Market, by Product Type
7.2 UK Arthritic Therapeutic Market
7.2.1 UK Arthritic Therapeutic Market, by Application
7.2.2 UK Arthritic Therapeutic Market, by Product Type
7.3 France Arthritic Therapeutic Market
7.3.1 France Arthritic Therapeutic Market, by Application
7.3.2 France Arthritic Therapeutic Market, by Product Type
7.4 Russia Arthritic Therapeutic Market
7.4.1 Russia Arthritic Therapeutic Market, by Application
7.4.2 Russia Arthritic Therapeutic Market, by Product Type
7.5 Spain Arthritic Therapeutic Market
7.5.1 Spain Arthritic Therapeutic Market, by Application
7.5.2 Spain Arthritic Therapeutic Market, by Product Type
7.6 Italy Arthritic Therapeutic Market
7.6.1 Italy Arthritic Therapeutic Market, by Application
7.6.2 Italy Arthritic Therapeutic Market, by Product Type
7.7 Rest of Europe Arthritic Therapeutic Market
7.7.1 Rest of Europe Arthritic Therapeutic Market, by Application
7.7.2 Rest of Europe Arthritic Therapeutic Market, by Product Type

Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Amgen, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Novartis AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.4.6 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Viatris, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Trials and Approvals:
8.6.6 SWOT Analysis
8.7 Bausch Health Companies, Inc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Bristol-Myers Squibb Company
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

TABLE 1 Europe Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 2 Europe Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 3 Europe Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 4 Europe Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 5 Europe Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 6 Europe Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 7 Europe Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 8 Europe Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 9 Europe Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 10 Europe Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 11 Europe Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 12 Europe Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 13 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 Europe Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 16 Europe Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 17 Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 18 Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 19 Europe Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 20 Europe Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 21 Europe Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 22 Europe Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 23 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 Europe Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 26 Europe Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 27 Germany Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 28 Germany Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 29 Germany Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 30 Germany Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 31 Germany Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 32 Germany Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 33 UK Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 34 UK Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 35 UK Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 36 UK Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 37 UK Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 38 UK Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 39 France Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 40 France Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 41 France Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 42 France Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 43 France Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 44 France Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 45 Russia Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 46 Russia Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 47 Russia Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 48 Russia Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 49 Russia Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 50 Russia Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 51 Spain Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 52 Spain Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 53 Spain Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 54 Spain Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 55 Spain Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 56 Spain Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 57 Italy Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 58 Italy Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 59 Italy Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 60 Italy Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 61 Italy Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 62 Italy Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 63 Rest of Europe Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 64 Rest of Europe Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 65 Rest of Europe Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 66 Rest of Europe Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 67 Rest of Europe Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 68 Rest of Europe Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 69 Key information – AbbVie, Inc.
TABLE 70 Key Information – Pfizer, Inc.
TABLE 71 Key Information – Amgen, Inc.
TABLE 72 Key Information – Novartis AG
TABLE 73 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 74 Key Information – Viatris, Inc.
TABLE 75 key information – Bausch Health Companies, Inc.
TABLE 76 Key Information – Sanofi S.A.
TABLE 77 Key Information - Merck & Co., Inc.
TABLE 78 Key Information – Bristol-Myers Squibb Company

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Arthritic Therapeutic Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Arthritic Therapeutic Market
FIG 4 Porter’s Five Forces Analysis - Arthritic Therapeutic Market
FIG 5 Europe Arthritic Therapeutic Market share, by Application, 2022
FIG 6 Europe Arthritic Therapeutic Market share, by Application, 2030
FIG 7 Europe Arthritic Therapeutic Market, by Application, 2019 - 2030, USD Million
FIG 8 Europe Arthritic Therapeutic Market share, by Product Type, 2022
FIG 9 Europe Arthritic Therapeutic Market share, by Product Type, 2030
FIG 10 Europe Arthritic Therapeutic Market, by Product Type, 2019 - 2030, USD Million
FIG 11 Europe Arthritic Therapeutic Market share, by Country, 2022
FIG 12 Europe Arthritic Therapeutic Market share, by Country, 2030
FIG 13 Europe Arthritic Therapeutic Market, by Country, 2019 - 2030, USD Million
FIG 14 Swot Analysis: AbbVie, Inc.
FIG 15 SWOT Analysis: Pfizer, Inc.
FIG 16 Swot Analysis: Amgen, Inc.
FIG 17 SWOT Analysis: Novartis AG
FIG 18 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: Viatris, Inc.
FIG 20 SWOT Analysis: Bausch Health Companies, Inc.
FIG 21 Swot Analysis: Sanofi S.A.
FIG 22 SWOT Analysis: Merck & Co., Inc.
FIG 23 SWOT Analysis: Bristol-Myers Squibb Company